Shopping Cart 0
Cart Subtotal
AED 0

Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Acorda Therapeutics Inc (ACOR)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. Its portfolio encomppases marketed products for the treatment of multiple sclerosis (MS) and for the intermittent treatment of people with Parkinson's taking carbidopa or levodopa who experience off episodes. It is also developing a pipeline of neurological therapies addressing a range of disorders, including migraine, MS, heart failure and spinal cord injury. The company sells its products through wholesale pharmaceutical distributors to retail pharmacies and specialty pharmacy providers. It has subsidiaries in the US and Europe. Acorda is headquartered in Ardsley, New York, the US.

Acorda Therapeutics Inc Key Recent Developments

Jun 03,2019: Acorda Therapeutics Debuts Art Exhibition inspired by people with Parkinson's at the 5th World Parkinson Congress

May 02,2019: Acorda provides update for first quarter ended march 31, 2019

Mar 08,2019: Acorda Therapeutics announces management changes

Feb 14,2019: Acorda provides financial and pipeline update for fourth quarter and year end 2018

Feb 04,2019: Acorda Therapeutics names Peter S. Carbone Senior Vice President, Quality

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Acorda Therapeutics Inc-Key Facts

Acorda Therapeutics Inc-Key Employees

Acorda Therapeutics Inc-Key Employee Biographies

Acorda Therapeutics Inc-Major Products and Services

Acorda Therapeutics Inc-History

Acorda Therapeutics Inc-Company Statement

Acorda Therapeutics Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Acorda Therapeutics Inc-Business Description

Product Category: Ampyra

Overview

Performance

Product Category: Inbrija

Overview

Product Category: Qutenza

Overview

Performance

Product Category: Net Product Revenue

Capital Expenditure

Product Category: Royalty Revenue

Performance

R&D Overview

Acorda Therapeutics Inc-Corporate Strategy

Acorda Therapeutics Inc-SWOT Analysis

SWOT Analysis-Overview

Acorda Therapeutics Inc-Strengths

Acorda Therapeutics Inc-Weaknesses

Acorda Therapeutics Inc-Opportunities

Acorda Therapeutics Inc-Threats

Acorda Therapeutics Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acorda Therapeutics Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Jun 03, 2019: Acorda Therapeutics Debuts Art Exhibition inspired by people with Parkinson's at the 5th World Parkinson Congress

May 02, 2019: Acorda provides update for first quarter ended march 31, 2019

Mar 08, 2019: Acorda Therapeutics announces management changes

Feb 14, 2019: Acorda provides financial and pipeline update for fourth quarter and year end 2018

Feb 04, 2019: Acorda Therapeutics names Peter S. Carbone Senior Vice President, Quality

Jan 07, 2019: Acorda Provides 2018 highlights and 2019 guidance at J.P. Morgan Healthcare Conference

Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson's symptoms

Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson's symptoms

Oct 31, 2018: Acorda provides financial and pipeline update for third quarter 2018

Aug 02, 2018: Acorda provides financial and pipeline update for second quarter 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Acorda Therapeutics Inc, Performance Chart (2014-2018)

Acorda Therapeutics Inc, Ratio Charts

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Acorda Therapeutics Inc, Key Facts

Acorda Therapeutics Inc, Key Employees

Acorda Therapeutics Inc, Key Employee Biographies

Acorda Therapeutics Inc, Major Products and Services

Acorda Therapeutics Inc, History

Acorda Therapeutics Inc, Other Locations

Acorda Therapeutics Inc, Subsidiaries

Acorda Therapeutics Inc, Key Competitors

Acorda Therapeutics Inc, Ratios based on current share price

Acorda Therapeutics Inc, Annual Ratios

Acorda Therapeutics Inc, Annual Ratios (Cont...1)

Acorda Therapeutics Inc, Annual Ratios (Cont...2)

Acorda Therapeutics Inc, Interim Ratios

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acorda Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Acorda Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Biogen Inc

Amneal Pharmaceuticals Inc

Sandoz International GmbH

AbbVie Inc

Intec Pharma Ltd

Genzyme Corp

Newron Pharmaceuticals SpA

F. Hoffmann-La Roche Ltd

Teva Pharmaceutical Industries Ltd

Merck & Co Inc

Bayer AG

Adamas Pharmaceuticals Inc

Company Profile

Company Profile Title

Acorda Therapeutics Inc (ACOR)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. Its portfolio encomppases marketed products for the treatment of multiple sclerosis (MS) and for the intermittent treatment of people with Parkinson's taking carbidopa or levodopa who experience off episodes. It is also developing a pipeline of neurological therapies addressing a range of disorders, including migraine, MS, heart failure and spinal cord injury. The company sells its products through wholesale pharmaceutical distributors to retail pharmacies and specialty pharmacy providers. It has subsidiaries in the US and Europe. Acorda is headquartered in Ardsley, New York, the US.

Acorda Therapeutics Inc Key Recent Developments

Jun 03,2019: Acorda Therapeutics Debuts Art Exhibition inspired by people with Parkinson's at the 5th World Parkinson Congress

May 02,2019: Acorda provides update for first quarter ended march 31, 2019

Mar 08,2019: Acorda Therapeutics announces management changes

Feb 14,2019: Acorda provides financial and pipeline update for fourth quarter and year end 2018

Feb 04,2019: Acorda Therapeutics names Peter S. Carbone Senior Vice President, Quality

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Acorda Therapeutics Inc-Key Facts

Acorda Therapeutics Inc-Key Employees

Acorda Therapeutics Inc-Key Employee Biographies

Acorda Therapeutics Inc-Major Products and Services

Acorda Therapeutics Inc-History

Acorda Therapeutics Inc-Company Statement

Acorda Therapeutics Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Acorda Therapeutics Inc-Business Description

Product Category: Ampyra

Overview

Performance

Product Category: Inbrija

Overview

Product Category: Qutenza

Overview

Performance

Product Category: Net Product Revenue

Capital Expenditure

Product Category: Royalty Revenue

Performance

R&D Overview

Acorda Therapeutics Inc-Corporate Strategy

Acorda Therapeutics Inc-SWOT Analysis

SWOT Analysis-Overview

Acorda Therapeutics Inc-Strengths

Acorda Therapeutics Inc-Weaknesses

Acorda Therapeutics Inc-Opportunities

Acorda Therapeutics Inc-Threats

Acorda Therapeutics Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acorda Therapeutics Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Jun 03, 2019: Acorda Therapeutics Debuts Art Exhibition inspired by people with Parkinson's at the 5th World Parkinson Congress

May 02, 2019: Acorda provides update for first quarter ended march 31, 2019

Mar 08, 2019: Acorda Therapeutics announces management changes

Feb 14, 2019: Acorda provides financial and pipeline update for fourth quarter and year end 2018

Feb 04, 2019: Acorda Therapeutics names Peter S. Carbone Senior Vice President, Quality

Jan 07, 2019: Acorda Provides 2018 highlights and 2019 guidance at J.P. Morgan Healthcare Conference

Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson's symptoms

Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson's symptoms

Oct 31, 2018: Acorda provides financial and pipeline update for third quarter 2018

Aug 02, 2018: Acorda provides financial and pipeline update for second quarter 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Acorda Therapeutics Inc, Performance Chart (2014-2018)

Acorda Therapeutics Inc, Ratio Charts

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Acorda Therapeutics Inc, Key Facts

Acorda Therapeutics Inc, Key Employees

Acorda Therapeutics Inc, Key Employee Biographies

Acorda Therapeutics Inc, Major Products and Services

Acorda Therapeutics Inc, History

Acorda Therapeutics Inc, Other Locations

Acorda Therapeutics Inc, Subsidiaries

Acorda Therapeutics Inc, Key Competitors

Acorda Therapeutics Inc, Ratios based on current share price

Acorda Therapeutics Inc, Annual Ratios

Acorda Therapeutics Inc, Annual Ratios (Cont...1)

Acorda Therapeutics Inc, Annual Ratios (Cont...2)

Acorda Therapeutics Inc, Interim Ratios

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acorda Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Acorda Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Biogen Inc

Amneal Pharmaceuticals Inc

Sandoz International GmbH

AbbVie Inc

Intec Pharma Ltd

Genzyme Corp

Newron Pharmaceuticals SpA

F. Hoffmann-La Roche Ltd

Teva Pharmaceutical Industries Ltd

Merck & Co Inc

Bayer AG

Adamas Pharmaceuticals Inc